当前位置: X-MOL 学术Cancer Cell › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Good Guy in Bad Company: How STRNs Convert PP2A into an Oncoprotein.
Cancer Cell ( IF 48.8 ) Pub Date : 2020-07-13 , DOI: 10.1016/j.ccell.2020.06.011
Kari J Kurppa 1 , Jukka Westermarck 2
Affiliation  

Certain Protein Phosphatase 2A (PP2A) complexes are human tumor suppressors. In contrast, a paper in this issue of Cancer Cell and two other recent studies demonstrate that PP2A-STRN3/4 complexes inactivate Hippo tumor suppressor pathway, resulting in YAP activation and tumorigenesis. Furthermore, this new oncogenic phosphatase mechanism may be druggable.



中文翻译:

坏公司里的好人:STRN 如何将 PP2A 转化为癌蛋白。

某些蛋白磷酸酶 2A (PP2A) 复合物是人类肿瘤抑制因子。相比之下,本期《Cancer Cell 》中的一篇论文和另外两项近期研究表明,PP2A-STRN3/4 复合物使 Hippo 肿瘤抑制通路失活,导致 YAP 激活和肿瘤发生。此外,这种新的致癌磷酸酶机制可能是可药用的。

更新日期:2020-07-13
down
wechat
bug